PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 4, 2012, Pages 683-692

  Gao, Haokao ^a,b   Lang, Lixin ^a   Guo, Ning ^a   Cao, Feng ^a   Quan, Qimeng ^a   Hu, Shuo ^a   Kiesewetter, Dale O ^a   Niu, Gang ^b,c   Chen, Xiaoyuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c NONE   (United States)

Author keywords

Angiogenesis; Integrin; Myocardial infarction; PET imaging; RGD peptide

Indexed keywords

A1F NOTA PRGD2 F 18; ARGINYLGLYCYLASPARTIC ACID; TRACER; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EX VIVO STUDY; HEART INFARCTION; HEART MUSCLE REPERFUSION; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; RAT;

EID: 84862776698     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-2052-1     Document Type: Article

References (35)

1. van der Laan AM, Piek JJ, van Royen N. Targeting angiogenesis to restore the microcirculation after reperfused MI. Nat Rev Cardiol 2009; 6:515-23.
2. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000; 5:40-6.
3. Jaffer FA, Sosnovik DE, Nahrendorf M, Weissleder R. Molecular imaging of myocardial infarction. J Mol Cell Cardiol 2006; 41:921-33.
4. Niu G, Chen X. Why integrin as a primary target for imaging and therapy. Theranostics 2011; 1:30-47.
5. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin avβ3 for angiogenesis. Science 1994; 264:569-71.
6. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, et al. Integrin avβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79:1157-64.
7. Eliceiri BP, Cheresh DA. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 1999; 103:1227-30.
8. Cai W, Niu G, Chen X. Imaging of integrins as biomarkers for tumor angiogenesis. Curr Pharm Des 2008; 14:2943-73.
9. Chen X. Integrin targeted imaging and therapy. Theranostics 2011; 1:28-9.
10. Johnson LL, Schofield L, Donahay T, Bouchard M, Poppas A, Haubner R. Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium. JACC Cardiovasc Imaging 2008; 1:500-10.
11. Meoli DF, Sadeghi MM, Krassilnikova S, Bourke BN, Giordano FJ, Dione DP, et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 2004; 113:1684-91.
12. 99mTc-RAFTRGD. J Nucl Cardiol 2010; 17:435-43.
13. Makowski MR, Ebersberger U, Nekolla S, Schwaiger M. In vivo molecular imaging of angiogenesis, targeting avβ3 integrin expression, in a patient after acute myocardial infarction. Eur Heart J 2008; 29:2201.
14. Higuchi T, Bengel FM, Seidl S, Watzlowik P, Kessler H, Hegenloh R, et al. Assessment of avβ3 integrin expression after myocardial infarction by positron emission tomography. Cardiovasc Res 2008; 78:395-403.
15. Zhang X, Xiong Z, Wu Y, Cai W, Tseng JR, Gambhir SS, et al. Quantitative PET imaging of tumor integrin avβ3 expression with 18F-FRGD2. J Nucl Med 2006; 47:113-21.
16. 18F-FDG PET of response to Abraxane therapy. J Nucl Med 2011; 52:140-6.
17. Jacobson O, Zhu L, Ma Y, Weiss ID, Sun X, Niu G, et al. Rapid and simple one-step F-18 labeling of peptides. Bioconjug Chem 2011; 22:422-8.
18. Jeong JM, Hong MK, Chang YS, Lee YS, Kim YJ, Cheon GJ, et al. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane- 1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med 2008; 49:830-6.
19. Li ZB, Chen K, Chen X. 68Ga-labeled multimeric RGD peptides for microPET imaging of integrin avβ3 expression. Eur J Nucl Med Mol Imaging 2008; 35:1100-8.
20. Liu Z, Niu G, Shi J, Liu S, Wang F, Chen X. 68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin avβ3 PET imaging. Eur J Nucl Med Mol Imaging 2009; 36:947-57.
21. McBride WJ, D'Souza CA, Sharkey RM, Karacay H, Rossi EA, Chang CH, et al. Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex. Bioconjug Chem 2010; 21:1331-40.
22. McBride WJ, Sharkey RM, Karacay H, D'Souza CA, Rossi EA, Laverman P, et al. A novel method of 18F radiolabeling for PET. J Nucl Med 2009; 50:991-8.
23. 18F-AlF-NOTA-RGD2 for tumor angiogenesis PET imaging. Eur J Nucl Med Mol Imaging 2011; 38:1732-41.
24. Lang L, Li W, Guo N, Ma Y, Zhu L, Kiesewetter DO, et al. Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. Bioconjug Chem 2011; 22:2415-22.
25. Wu JC, Chen IY, Wang Y, Tseng JR, Chhabra A, Salek M, et al. Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation 2004; 110:685-91.
26. Rodriguez-Porcel M, Gheysens O, Chen IY, Wu JC, Gambhir SS. Image-guided cardiac cell delivery using high-resolution smallanimal ultrasound. Mol Ther 2005; 12:1142-7.
27. Yang M, Gao H, Yan Y, Sun X, Chen K, Quan Q, et al. PET imaging of early response to the tyrosine kinase inhibitor ZD4190. Eur J Nucl Med Mol Imaging 2011; 38:1237-47.
28. van den Borne SW, Isobe S, Verjans JW, Petrov A, Lovhaug D, Li P, et al. Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol 2008; 52:2017-28.
29. Haubner R, Wester HJ, Reuning U, Senekowitsch-Schmidtke R, Diefenbach B, Kessler H, et al. Radiolabeled avβ3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med 1999; 40:1061-71.
30. Liu S, Liu Z, Chen K, Yan Y, Watzlowik P, Wester HJ, et al. 18Flabeled galacto and PEGylated RGD dimers for PET imaging of avβ3 integrin expression. Mol Imaging Biol 2010; 12:530-8.
31. Boturyn D, Coll JL, Garanger E, Favrot MC, Dumy P. Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis. J Am Chem Soc 2004; 126:5730-9.
32. Mittra ES, Goris ML, Iagaru AH, Kardan A, Burton L, Berganos R, et al. Pilot pharmacokinetic and dosimetric studies of 18FFPPRGD2: a PET radiopharmaceutical agent for imaging avβ3 integrin levels. Radiology 2011; 260:182-91.
33. Frangogiannis NG, Michael LH, Entman ML. Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc Res 2000; 48:89-1=0.
34. Razavian M, Marfatia R, Mongue-Din H, Tavakoli S, Sinusas AJ, Zhang J, et al. Integrin-targeted imaging of inflammation in vascular remodeling. Arterioscler Thromb Vasc Biol 2011; 31:2820-6.
35. Verjans J,Wolters S, LauferW, SchellingsM, Lax M, Lovhaug D, et al. Early molecular imaging of interstitial changes in patients after myocardial infarction: comparison with delayed contrast-enhanced magnetic resonance imaging. J Nucl Cardiol 2010; 17:1065-72.